Form 4 for BIAF bioAffinity Technologies, Inc.
Accepted 2024-03-29 00:00:00 ET · period of report 2024-02-26 · accession 0001493152-24-012011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-29 | 2024-02-26 | BIAF | Anderson Robert A. | Dir | M - OptEx | $1.16 | +64.8K | 121.9K | +114% | +$75.2K |
| D | 2024-03-29 | 2024-02-26 | BIAF | Anderson Robert A. | Dir | M - OptEx | $0.00 | -64.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-26 | M | A | 64,848 | $1.16 | 121,856 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-02-26 | M | D | 64,848 | $0.00 | 0 | D | $1.12 · — to 2024-04-28 | 64,848 Common Stock | (F1) This option vested in 7 equal monthly installments beginning on May 28, 2014 and the balance of such option vested on December 28, 2014. |